companydata.dkcompanydata.dk

Pharmaway Invest ApS: Financial statements 2019

CVR: 38585126

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -12,500 and a net result of DKK -14,676 compared with DKK -6,266 the year before. Equity in the 2019 report amounted to DKK 33,848,433. The solvency ratio was 99.6%.

Gross Profit
DKK -12,500
Profit/Loss
DKK -14,676
Equity
DKK 33,848,433
Total Assets
DKK 34,000,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--13K-15K33.8M-
2018--4K-6K33.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Pharmaway Invest ApS: The 2018 annual report is outMay 27, 2019

Pharmaway Invest ApS has published its annual report for 2018. Gross profit came to DKK -4,375, and the net result was DKK -6,266.

About Pharmaway Invest ApS

Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.

Source: annual report 2025, Danish Business Authority

Other financial years